Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Updated: Oct 19, 2026
Mohit Bansal's Stock Ratings
Wells Fargo Analyst
Mohit Bansal is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
10.6%
Smart Score
Overall Average Return Percentile
61st
Number of Ratings
100
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/13/2026 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | 2.02% | $65 → $60 | Maintains | Equal-Weight | Get Alert | |
| 10/12/2026 | AMGN | Buy Now | Amgen | $424.94 | 1.19% | $435 → $430 | Maintains | Equal-Weight | Get Alert | |
| 09/04/2026 | AMGN | Buy Now | Amgen | $424.94 | 2.37% | $400 → $435 | Maintains | Equal-Weight | Get Alert | |
| 09/04/2026 | MRK | Buy Now | Merck & Co | $143.85 | 18.18% | $150 → $170 | Maintains | Overweight | Get Alert | |
| 08/17/2026 | ABBV | Buy Now | AbbVie | $282.60 | 6.16% | $295 → $300 | Maintains | Overweight | Get Alert | |
| 08/07/2026 | HALO | Buy Now | Halozyme Therapeutics | $123.60 | -23.14% | $75 → $95 | Maintains | Equal-Weight | Get Alert | |
| 08/06/2026 | LLY | Buy Now | Eli Lilly | $1.24K | 7.08% | $1280 → $1330 | Maintains | Overweight | Get Alert | |
| 08/05/2026 | AMGN | Buy Now | Amgen | $424.94 | -5.87% | $390 → $400 | Maintains | Equal-Weight | Get Alert | |
| 08/04/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $208.43 | 43.93% | $285 → $300 | Maintains | Overweight | Get Alert | |
| 07/31/2026 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | 10.52% | $60 → $65 | Maintains | Equal-Weight | Get Alert | |
| 07/31/2026 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | -4.09% | $700 → $750 | Maintains | Equal-Weight | Get Alert | |
| 07/17/2026 | NBIX | Buy Now | Neurocrine Biosciences | $136.98 | 46.01% | $175 → $200 | Maintains | Overweight | Get Alert | |
| 07/14/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $208.43 | 36.74% | $265 → $285 | Maintains | Overweight | Get Alert | |
| 07/10/2026 | ABBV | Buy Now | AbbVie | $282.60 | 4.39% | $260 → $295 | Maintains | Overweight | Get Alert | |
| 07/08/2026 | MRK | Buy Now | Merck & Co | $143.85 | 4.28% | $145 → $150 | Maintains | Overweight | Get Alert | |
| 06/12/2026 | TVTX | Buy Now | Travere Therapeutics | $49.83 | 30.44% | $50 → $65 | Maintains | Overweight | Get Alert | |
| 05/18/2026 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | -10.49% | $800 → $700 | Maintains | Equal-Weight | Get Alert | |
| 05/14/2026 | MIST | Buy Now | Milestone Pharmaceuticals | $0.72 | 872.22% | $8 → $7 | Maintains | Overweight | Get Alert | |
| 05/06/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $208.43 | 27.14% | $250 → $265 | Maintains | Overweight | Get Alert | |
| 05/06/2026 | TVTX | Buy Now | Travere Therapeutics | $49.83 | 0.34% | $40 → $50 | Maintains | Overweight | Get Alert | |
| 05/06/2026 | BNTX | Buy Now | BioNTech | $89.21 | 56.93% | $150 → $140 | Maintains | Overweight | Get Alert | |
| 05/01/2026 | MRK | Buy Now | Merck & Co | $143.85 | 0.8% | $150 → $145 | Maintains | Overweight | Get Alert | |
| 04/30/2026 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | 2.3% | $825 → $800 | Maintains | Equal-Weight | Get Alert | |
| 04/20/2026 | BIIB | Buy Now | Biogen | $236.00 | 5.93% | $200 → $250 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 03/12/2026 | MRK | Buy Now | Merck & Co | $143.85 | 4.28% | $135 → $150 | Maintains | Overweight | Get Alert | |
| 02/25/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $208.43 | 19.94% | $235 → $250 | Maintains | Overweight | Get Alert | |
| 02/19/2026 | HALO | Buy Now | Halozyme Therapeutics | $123.60 | -39.32% | $65 → $75 | Maintains | Equal-Weight | Get Alert | |
| 02/19/2026 | AMGN | Buy Now | Amgen | $424.94 | -11.75% | $325 → $375 | Maintains | Equal-Weight | Get Alert | |
| 02/18/2026 | BMRN | Buy Now | BioMarin Pharmaceutical | $54.60 | 37.36% | $70 → $75 | Maintains | Overweight | Get Alert | |
| 02/13/2026 | NBIX | Buy Now | Neurocrine Biosciences | $136.98 | 27.76% | $180 → $175 | Maintains | Overweight | Get Alert | |
| 02/11/2026 | GILD | Buy Now | Gilead Sciences | $153.33 | 7.61% | $150 → $165 | Maintains | Overweight | Get Alert | |
| 02/09/2026 | BIIB | Buy Now | Biogen | $236.00 | -15.25% | $190 → $200 | Maintains | Equal-Weight | Get Alert | |
| 02/06/2026 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | 2.02% | $55 → $60 | Maintains | Equal-Weight | Get Alert | |
| 02/05/2026 | LLY | Buy Now | Eli Lilly and Co | $1.24K | 3.05% | $1200 → $1280 | Maintains | Overweight | Get Alert | |
| 02/04/2026 | MRK | Buy Now | Merck & Co | $143.85 | -6.15% | $125 → $135 | Maintains | Overweight | Get Alert | |
| 02/02/2026 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | 2.3% | $745 → $800 | Maintains | Equal-Weight | Get Alert | |
| 01/05/2026 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.56 | 40.45% | $3 → $5 | Maintains | Equal-Weight | Get Alert | |
| 12/16/2025 | MIST | Buy Now | Milestone Pharmaceuticals | $0.72 | 1011.11% | $4 → $8 | Maintains | Overweight | Get Alert | |
| 12/10/2025 | LLY | Buy Now | Eli Lilly | $1.24K | -3.39% | $1100 → $1200 | Maintains | Overweight | Get Alert | |
| 12/10/2025 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | -6.48% | $53 → $55 | Maintains | Equal-Weight | Get Alert | |
| 12/10/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | 0.56% | $460 → $515 | Maintains | Overweight | Get Alert | |
| 12/10/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | -4.73% | $700 → $745 | Maintains | Equal-Weight | Get Alert | |
| 12/10/2025 | GILD | Buy Now | Gilead Sciences | $153.33 | -2.17% | $145 → $150 | Maintains | Overweight | Get Alert | |
| 12/10/2025 | BIIB | Buy Now | Biogen | $236.00 | -19.49% | $155 → $190 | Maintains | Equal-Weight | Get Alert | |
| 12/10/2025 | AMGN | Buy Now | Amgen | $424.94 | -23.52% | $300 → $325 | Maintains | Equal-Weight | Get Alert | |
| 11/24/2025 | MRK | Buy Now | Merck & Co | $143.85 | -13.1% | $90 → $125 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 11/20/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | -10.49% | $615 → $700 | Maintains | Equal-Weight | Get Alert | |
| 11/18/2025 | JAZZ | Buy Now | Jazz Pharmaceuticals | $208.43 | 12.75% | $170 → $235 | Maintains | Overweight | Get Alert | |
| 11/11/2025 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.56 | -15.73% | $1 → $3 | Maintains | Equal-Weight | Get Alert | |
| 11/11/2025 | MLYS | Buy Now | Mineralys Therapeutics | $20.92 | 162.91% | $50 → $55 | Maintains | Overweight | Get Alert | |
| 11/05/2025 | AMGN | Buy Now | Amgen | $424.94 | -29.4% | $280 → $300 | Maintains | Overweight | Get Alert | |
| 10/31/2025 | GILD | Buy Now | Gilead Sciences | $153.33 | -5.43% | $140 → $145 | Maintains | Overweight | Get Alert | |
| 10/29/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | -21.36% | $580 → $615 | Maintains | Equal-Weight | Get Alert | |
| 10/28/2025 | BMRN | Buy Now | BioMarin Pharmaceutical | $54.60 | 28.2% | $90 → $70 | Maintains | Overweight | Get Alert | |
| 09/12/2025 | ABBV | Buy Now | AbbVie | $282.60 | -8% | $240 → $260 | Maintains | Overweight | Get Alert | |
| 09/11/2025 | TVTX | Buy Now | Travere Therapeutics | $49.83 | -29.76% | $27 → $35 | Maintains | Overweight | Get Alert | |
| 09/11/2025 | MLYS | Buy Now | Mineralys Therapeutics | $20.92 | 139.01% | $26 → $50 | Maintains | Overweight | Get Alert | |
| 09/11/2025 | MIST | Buy Now | Milestone Pharmaceuticals | $0.72 | 455.56% | → $4 | Initiates | → Overweight | Get Alert | |
| 08/06/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -10.18% | $460 → $460 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 08/05/2025 | BNTX | Buy Now | BioNTech | $89.21 | 68.14% | $170 → $150 | Maintains | Overweight | Get Alert | |
| 07/30/2025 | MRK | Buy Now | Merck & Co | $143.85 | -37.43% | $97 → $90 | Maintains | Equal-Weight | Get Alert | |
| 05/30/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | -25.83% | $700 → $580 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 05/13/2025 | XENE | Buy Now | Xenon Pharmaceuticals | $35.08 | 33.98% | $50 → $47 | Maintains | Overweight | Get Alert | |
| 05/07/2025 | HALO | Buy Now | Halozyme Therapeutics | $123.60 | -47.41% | $60 → $65 | Maintains | Equal-Weight | Get Alert | |
| 04/30/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | -10.49% | $750 → $700 | Maintains | Overweight | Get Alert | |
| 04/28/2025 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | -9.88% | $62 → $53 | Maintains | Equal-Weight | Get Alert | |
| 04/15/2025 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.56 | -71.91% | $7 → $1 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 03/05/2025 | LLY | Buy Now | Eli Lilly | $1.24K | -11.44% | $970 → $1100 | Maintains | Overweight | Get Alert | |
| 03/05/2025 | GILD | Buy Now | Gilead Sciences | $153.33 | -8.69% | $120 → $140 | Maintains | Overweight | Get Alert | |
| 03/05/2025 | ABBV | Buy Now | AbbVie | $282.60 | -15.07% | $210 → $240 | Maintains | Overweight | Get Alert | |
| 02/13/2025 | BIIB | Buy Now | Biogen | $236.00 | -40.68% | $165 → $140 | Maintains | Equal-Weight | Get Alert | |
| 02/13/2025 | JAZZ | Buy Now | Jazz Pharmaceuticals | $208.43 | -18.44% | $130 → $170 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 02/12/2025 | GILD | Buy Now | Gilead Sciences | $153.33 | -21.74% | $105 → $120 | Maintains | Overweight | Get Alert | |
| 02/07/2025 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | 5.42% | $60 → $62 | Maintains | Equal-Weight | Get Alert | |
| 02/03/2025 | ABBV | Buy Now | AbbVie | $282.60 | -25.69% | $195 → $210 | Maintains | Overweight | Get Alert | |
| 01/30/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -10.18% | $460 → $460 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 01/28/2025 | LLY | Buy Now | Eli Lilly | $1.24K | -21.91% | $1000 → $970 | Maintains | Overweight | Get Alert | |
| 01/13/2025 | HALO | Buy Now | Halozyme Therapeutics | $123.60 | -53.88% | $62 → $57 | Maintains | Equal-Weight | Get Alert | |
| 01/10/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -10.18% | $555 → $460 | Maintains | Overweight | Get Alert | |
| 01/10/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | 15.09% | $1050 → $900 | Maintains | Overweight | Get Alert | |
| 01/10/2025 | BIIB | Buy Now | Biogen | $236.00 | -30.08% | $190 → $165 | Maintains | Equal-Weight | Get Alert | |
| 01/10/2025 | AMGN | Buy Now | Amgen | $424.94 | -34.11% | $335 → $280 | Maintains | Equal-Weight | Get Alert | |
| 12/11/2024 | SMMT | Buy Now | Summit Therapeutics | $15.36 | 95.36% | → $30 | Initiates | → Overweight | Get Alert | |
| 12/11/2024 | BNTX | Buy Now | BioNTech | $89.21 | 90.56% | → $170 | Initiates | → Overweight | Get Alert | |
| 11/21/2024 | VERA | Buy Now | Vera Therapeutics | $28.35 | 146.91% | → $70 | Initiates | → Overweight | Get Alert | |
| 11/18/2024 | ABBV | Buy Now | AbbVie | $282.60 | -31% | $205 → $195 | Maintains | Overweight | Get Alert | |
| 11/07/2024 | GILD | Buy Now | Gilead Sciences | $153.33 | -31.52% | $100 → $105 | Maintains | Overweight | Get Alert | |
| 11/01/2024 | MRK | Buy Now | Merck & Co | $143.85 | -23.53% | $125 → $110 | Maintains | Equal-Weight | Get Alert | |
| 10/31/2024 | BIIB | Buy Now | Biogen | $236.00 | -19.49% | $225 → $190 | Maintains | Equal-Weight | Get Alert | |
| 10/22/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | 34.27% | $1200 → $1050 | Maintains | Overweight | Get Alert | |
| 10/21/2024 | TVTX | Buy Now | Travere Therapeutics | $49.83 | -45.82% | $9 → $27 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 10/07/2024 | HALO | Buy Now | Halozyme Therapeutics | $123.60 | -49.84% | $58 → $62 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 10/07/2024 | GILD | Buy Now | Gilead Sciences | $153.33 | -34.78% | $78 → $100 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 09/23/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | 53.45% | $1200 → $1200 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/17/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 64.83% | $115 → $90 | Maintains | Overweight | Get Alert | |
| 08/09/2024 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.56 | 237.08% | $14 → $12 | Maintains | Overweight | Get Alert | |
| 08/09/2024 | LLY | Buy Now | Eli Lilly | $1.24K | -19.49% | $875 → $1000 | Maintains | Overweight | Get Alert | |
| 08/07/2024 | AMGN | Buy Now | Amgen | $424.94 | -21.17% | $320 → $335 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 08/02/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | 53.45% | $1125 → $1200 | Maintains | Overweight | Get Alert | |
| 08/02/2024 | BIIB | Buy Now | Biogen | $236.00 | -4.66% | $240 → $225 | Maintains | Equal-Weight | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved